In our recent work, we performed ICS to determine IFNγ expression, a common indicator of T cell responses (4), in crude spleen and lung tissue-dissociated cells as a means of assessing cancer-associated systemic immunosuppression at the early tumor progression stage. Here, IFNG is linked to cancer.